The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...

It stressed there were no issues with "clinical efficacy or safety, trial design, labelling, or manufacturing" that could suggest a lengthy delay. The EU approval is based on the results of the ...